Who we are

Hej!
Welcome to PharmaLex Sweden

The Swedish team is comprised of dedicated professionals with backgrounds in the pharmaceutical industry, the pharmacy profession and academic research institutes. Our ambition is to produce creative, high-quality work meeting the highest standards of scientific rigor and real-world applicability.

 

  • According to therapeutic area, business potential, and company resources, we support our clients within health economics, reimbursement, real-world evidence, and market access strategy, as well as local PV/REG consultancy.

 

  • The team have in-depth knowledge of the Nordic market culture and authorities` expectations, while also providing the know-how to assist our Nordic clients in accessing mature international markets.

 

  • As part of the global PharmaLex group, PharmaLex Sweden is your local point of contact reaching the entire PharmaLex service portfolio, servicing more than 600 national and global companies

Local Contact

  • Åsa Pihlblad
    Country Manager - PharmaLex Sweden PharmaLex Sweden Medicinaregatan 8B
    Gothenburg
    SE-413 90
    Sweden    +46 31 724 22 01
Download Terms and Conditions
Explore PharmaLex Market Access offersEarly Phase Modeling InfographicVirtual GxP AuditsReal World Evidence Fact Flyer

PharmaLex.perts to guide you for HTA advice that makes a difference

Since 2003, PharmaLex Sweden, formerly known as Nordic Health Economics, offers highly qualified health-economic services throughout the development process of pharmaceuticals and medical technology-products.

We start by offering strategic advice in the early stages of product development, on how product opportunities and challenges could be addressed to optimize the possibilities for inclusion into reimbursement schemes. We then follow this by developing the core material in preparation of reimbursement applications, and if applicable, also including collection of Real-World-Evidence to support the cost-effectiveness of the product. We have an unparalleled base of knowledge how to effectively develop the appropriate evidence according to legislation and policies of the boards in the respective countries, and how to communicate the results in a manner that clearly presents relevant information and the validity of the results.

Get in touch to see how we can be of service.

Related News

What our clients say about us

We are working with a number of large pharma companies and are looking to create a consortium of partners to collect feedback on expertise, availability and outcomes. If you would be interested in joining our consortium, please contact us on contact@pharmalex.com.

  • We needed to develop our strategy and PharmaLex had exactly the experience we needed.

    Med Device company, UK
    Senior QA Director

  • Highly competent, knowledgeable, absolutely reliable and dedicated to the projects

    Europe based medium-sized biotech development company
    Senior Director

  • They are available when we need to talk to them despite any time zone differentials

    Japan based medium sized company
    Manager

  • Our project team were very impressed with the quality of the research and the reports that you sent through. We didn’t need any convincing that your recommendations should be followed. It showed PharmaLex in a very positive light, and the Project Team are keen to work with you again.

    Leading European Specialist Pharma Company
    Head of Medical Writing and Publications